Onto Innovation Forecasts 30% Revenue Growth for 2026: Can It Deliver?

Onto Innovation expects more than 30% revenue growth in 2026 to above $1.3 billion, supported by AI-driven demand and advanced semiconductor spending. Q1 2026 revenue rose 9.5% year over year to $291.9 million, and Q2 guidance of $320 million-$330 million implies roughly 28% growth at the midpoint. The company also sees advanced packaging up more than 50% and advanced nodes nearly 25% in 2026, while its $710 million Rigaku stake expands its metrology and inspection capabilities.

Analysis

ONTO is becoming the cleaner lever on the AI capex cycle because it sits closer to the “quality-control tollbooth” than to pure wafer-volume beta. If advanced packaging and leading-edge memory continue to outgrow the broader WFE market, process-control budgets should stay structurally elevated even if customers rationalize elsewhere; that makes ONTO’s growth more durable than a typical semiconductor equipment upcycle. The bigger second-order effect is that every additional layer of complexity in HBM, hybrid bonding, and advanced packaging raises defect-intolerance, which tends to expand the value per wafer for inspection/metrology vendors faster than wafer counts alone would imply.

The competitive read-through is that KLAC remains the more defensive compounder, but ONTO may have the higher operating leverage if its new platforms keep taking share. Nova’s strength confirms the memory mix is not just an ONTO-specific story, but ONTO’s exposure to packaging plus node complexity gives it a broader capture mechanism than a single memory-cycle rebound. That said, the stock is already discounting a lot of the upside; when a name trades at a premium multiple into a forecast acceleration, the market usually needs continued estimate revisions, not just good prints, to sustain rerating.

The key risk is execution and digestion, not demand. Material, freight, and R&D inflation can compress incremental margins just as revenue inflects, and any pause in customer qualification cycles would hit the multiple before it hits the top line. Over 1-3 months the stock can continue to grind higher on revisions, but over 6-12 months the setup is vulnerable if 2026 growth is front-loaded and backlog conversion slows after the first half.

The contrarian angle is that the market may be overpaying for “AI exposure” while underestimating how cyclical semiconductor process-control spending still is. If memory and packaging spend normalize after the current buildout, ONTO could see a growth air pocket even if the secular narrative remains intact. In that scenario, KLAC’s scale and broader customer base likely absorb the slowdown better than ONTO, making relative-value positioning more attractive than outright chasing the stock higher.

Key Decisions for Investors

• Stay long ONTO into the next 1-2 earnings windows, but size it as a momentum/revision trade rather than a long-duration compounder; upside remains if 2H backlog converts, but the multiple leaves limited cushion if guidance merely confirms instead of raises.
• Pair trade: long ONTO / short a basket of higher-quality, lower-beta semiconductor capital equipment names over 3-6 months only if you want to express packaging/metrology outperformance; otherwise prefer long KLAC / short ONTO as the cleaner way to isolate valuation compression risk.
• Use call spreads rather than outright longs on ONTO for the next 90 days — e.g., buy near-the-money calls and finance with higher strikes — because the stock can still re-rate on estimate revisions, but the premium leaves little room for disappointment.
• If NOVA continues to print strong memory-metrology demand, consider pairing long NVMI against ONTO on any ONTO outperformance days; NVMI has more direct memory leverage and a lower bar for incremental upside surprise.
• Take profits on any ONTO breakout that is driven by guidance commentary rather than order acceleration; if the stock rerates before 2H shipments inflect, the risk/reward shifts from favorable to crowded quickly.